⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23890643 | 1.00 | — | — | |
| SCHEMBL28416159 | 0.87 | LMNA (0.38) | — | |
| SCHEMBL10755396 | 0.82 | LMNA (0.50) | — | |
| SCHEMBL7679680 | 0.80 | — | — | |
| SCHEMBL10755399 | 0.80 | ALDH1A1 (0.37) | — | |
| SCHEMBL9084620 | 0.78 | LMNA (0.50) | — | |
| SCHEMBL9084633 | 0.78 | LMNA (0.50) | — | |
| SCHEMBL7670411 | 0.77 | — | — | |
| SCHEMBL3026953 | 0.77 | — | — | |
| Isobutyraldehyde SCHEMBL427264 | 0.77 | LMNA (0.67) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117120476-A | Antibodies specific for structurally disordered sequences | XL-普洛坦公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4267628-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-protein GmbH (DE) | 2023-11-01 | — | — | EP | claimed |
| US-20230128452-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTALENERGIES ONETECH (FR) | 2023-04-27 | — | — | US | claimed |
| EP-4136124-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTALENERGIES ONETECH (FR) | 2023-02-22 | — | — | EP | claimed |
| CN-115698092-A | Monomers, oligomers and polymers of saccharides functionalized with linear or branched fatty acids and derivatives, compositions and uses thereof | 道达尔能源技术公司 | 2023-02-03 | — | — | CN | claimed |
| WO-2022136582-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-PROTEIN GMBH (DE) | 2022-06-30 | — | — | WO | claimed |
| WO-2021209621-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTAL MARKETING SERVICES (FR) | 2021-10-21 | — | — | WO | claimed |
| US-20200282071-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2020-09-10 | — | — | US | claimed |
| EP-3641827-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-protein GmbH (DE) | 2020-04-29 | — | — | EP | claimed |
| CN-110891612-A | Conjugates of protein drugs and P/A peptides | XL-蛋白有限责任公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2018234455-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2018-12-27 | — | — | WO | claimed |
| EP-1780197-B9 | 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2011-04-06 | — | — | EP | claimed |
| EP-1780197-B1 | 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2010-10-20 | — | — | EP | claimed |
| US-7745663-B2 | 5-Substituted-2-phenylamino benzamides as MEK inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-06-29 | — | — | US | claimed |
| US-20090233915-A1 | 5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-09-17 | — | — | US | claimed |
| EP-1780197-A1 | 5-SUBSTITUTED-2-PHENYLAMINO-BENZAMIDE AS MEK INHIBITOR | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-05-02 | — | — | EP | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-11993578-B2 | Pyrazole-3-carboxylic acid amide derivative and pest control agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| US-11964957-B2 | Pyrazole derivative and harmful organism-controlling agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-04-23 | — | — | US | disclosed |
| EP-3808738-B1 | PYRAZOLE DERIVATIVE AND HARMFUL ORGANISM-CONTROLLING AGENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2024-04-17 | — | — | EP | disclosed |
| CN-112236421-B | Pyrazole derivatives and pest control agents | 组合化学工业株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-117120476-A | Antibodies specific for structurally disordered sequences | XL-普洛坦公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-4267628-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-protein GmbH (DE) | 2023-11-01 | — | — | EP | disclosed |
| CN-110612295-B | Pyrazole-3-carboxylic acid amide derivative and pest control agent | 组合化学工业株式会社 | 2023-07-14 | — | — | CN | disclosed |
| US-20230128452-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTALENERGIES ONETECH (FR) | 2023-04-27 | — | — | US | disclosed |
| US-20230110603-A1 | 3-ALKOXYBENZAMIDE DERIVATIVE, AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-04-13 | — | — | US | disclosed |
| EP-4136124-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTALENERGIES ONETECH (FR) | 2023-02-22 | — | — | EP | disclosed |
| CN-115698092-A | Monomers, oligomers and polymers of saccharides functionalized with linear or branched fatty acids and derivatives, compositions and uses thereof | 道达尔能源技术公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-3623365-B1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2023-01-04 | — | — | EP | disclosed |
| EP-4098650-A1 | 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2022-12-07 | — | — | EP | disclosed |
| CN-115052856-A | 3-alkoxybenzamide derivative and pest control agent | 组合化学工业株式会社 | 2022-09-13 | — | — | CN | disclosed |
| WO-2022136582-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-PROTEIN GMBH (DE) | 2022-06-30 | — | — | WO | disclosed |
| WO-2021209621-A1 | MONOMERS, OLIGOMERS AND POLYMERS OF SUGARS FUNCTIONALIZED WITH STRAIGHT OR BRANCHED FATTY ACIDS AND DERIVATIVES, THEIR COMPOSITIONS AND USES | TOTAL MARKETING SERVICES (FR) | 2021-10-21 | — | — | WO | disclosed |
| WO-2021153720-A1 | 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT | クミアイ化学工業株式会社 | 2021-08-05 | — | — | WO | disclosed |
| EP-3808738-A1 | PYRAZOLE DERIVATIVE AND HARMFUL ORGANISM-CONTROLLING AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2021-04-21 | — | — | EP | disclosed |
| CN-112236421-A | Pyrazole derivative and pest control agent | 组合化学工业株式会社 | 2021-01-15 | — | — | CN | disclosed |
| US-20200282071-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2020-09-10 | — | — | US | disclosed |
| CN-111533767-A | Tetradentate phosphine ligand and preparation method thereof, hydroformylation catalyst and reaction method, and preparation method of 1, 3-propylene glycol | 卢海元 | 2020-08-14 | — | — | CN | disclosed |
| US-20200199096-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3641827-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-protein GmbH (DE) | 2020-04-29 | — | — | EP | disclosed |
| EP-3623365-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110891612-A | Conjugates of protein drugs and P/A peptides | XL-蛋白有限责任公司 | 2020-03-17 | — | — | CN | disclosed |
| WO-2020036134-A1 | 5-(1,2,4-TRIAZOLE-5-YL) BENZOIC ACID AMIDE DERIVATIVE AND HARMFUL ORGANISM CONTROL AGENT | クミアイ化学工業株式会社 | 2020-02-20 | — | — | WO | disclosed |
| CN-110612295-A | Pyrazole-3-carboxylic acid amide derivative and pest control agent | 组合化学工业株式会社 | 2019-12-24 | — | — | CN | disclosed |
| WO-2018234455-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2018-12-27 | — | — | WO | disclosed |
| EP-2346831-B1 | HETEROARYL DIAMIDE COMPOUNDS USEFUL AS MMP-13 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2015-01-07 | — | — | EP | disclosed |
| WO-2014202027-A1 | SPIROCYCLIC DERIVATIVE OF 4,5-DIHYDROPYRAZOLO[3,4-C]PYRIDINE-2-ONE, PREPARATION METHOD AND USE THEREOF | 四川海思科制药有限公司 (CN) | 2014-12-24 | — | — | WO | disclosed |
| US-8575391-B2 | 5-substituted-2-phenylamino benzamides as MEK inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20130059360-A1 | POLYMER-BASED COMPOSITIONS AND CONJUGATES OF ANTIMICROBIAL AGENTS | NEKTAR THERAPEUTICS (US) | 2013-03-07 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| CN-101585934-B | Low-smoke and halogen-free fire-retardant rubber material for covering layer of conveyor belt and preparation method thereof | UNIV BEIJING CHEMICAL | 2011-05-11 | — | — | CN | disclosed |
| EP-1780197-B9 | 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2011-04-06 | — | — | EP | disclosed |
| EP-1780197-B1 | 5-SUBSTITUTED-2-PHENYLAMINO BENZAMIDES AS MEK INHIBITORS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100197676-A1 | 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-1460657-B1 | Method of manufacturing magnetic particle, magnetic particle and magnetic recording medium | FUJIFILM CORP (JP) | 2010-07-07 | — | — | EP | disclosed |
| US-7745663-B2 | 5-Substituted-2-phenylamino benzamides as MEK inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-06-29 | — | — | US | disclosed |
| CN-101585934-A | Low-smoke and halogen-free fire-retardant rubber material for covering layer of conveyor belt and preparation method thereof | UNIV BEIJING CHEMICAL (CN) | 2009-11-25 | — | — | CN | disclosed |
| US-20090233915-A1 | 5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-09-17 | — | — | US | disclosed |
| US-7544230-B2 | preparing an alloy particle capable of forming a CuAu type or Cu3Au type hard magnetic ordered alloy phase; preparing a magnetic particle using a mixing and reaction device which has a stirring vane rotating at a high speed in the interior of a mixer in a liquid phase process | FUJIFILM CORPORATION (JP) | 2009-06-09 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1780197-A1 | 5-SUBSTITUTED-2-PHENYLAMINO-BENZAMIDE AS MEK INHIBITOR | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-05-02 | — | — | EP | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-20050287202-A1 | Compound | MILLER ANDREW D | 2005-12-29 | — | — | US | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| US-20040231462-A1 | preparing an alloy particle capable of forming a CuAu type or Cu3Au type hard magnetic ordered alloy phase; preparing a magnetic particle using a mixing and reaction device which has a stirring vane rotating at a high speed in the interior of a mixer in a liquid phase process | FUJI PHOTO FILM CO., LTD. | 2004-11-25 | — | — | US | disclosed |
| US-20040231463-A1 | preparing an alloy particle capable of forming a CuAu type or Cu3Au type hard magnetic ordered alloy phase; preparing a magnetic particle using a mixing and reaction device which has a stirring vane rotating at a high speed in the interior of a mixer in a liquid phase process | FUJI PHOTO FILM CO., LTD. | 2004-11-25 | — | — | US | disclosed |
| EP-1460657-A1 | Method of manufacturing magnetic particle, magnetic particle and magnetic recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6462234-B2 | FORMED BY REACTING O-ETHYL-L-TYROSINE WITH TRIFLUOROACETIC ANHYDRIDE, REACTING WITH LEWIS ACID, THEN QUENCHING WITH WATER | PHARMACIA & UPJOHN COMPANY | 2002-10-08 | — | — | US | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| US-20010016229-A1 | Ferroelectric thin films and solutions: compositions and processing | MONTEREY RESEARCH, LLC | 2001-08-23 | — | — | US | disclosed |
| US-6203608-B1 | POLARIZATION, RETENTION AND IMPRINT CHARACTERISTICS AS, MINUTE GRAINS AND FINE FILM QUALITY, HOMOGENEOUS ELECTRICAL PROPERTIES, LOW LEAKAGE CURRENT; SUITED FOR NONVOLATILEMEMORIES | RAMTRON INTERNATIONAL CORPORATION | 2001-03-20 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| EP-0994858-A1 | 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | Ortho-McNeil Pharmaceutical, Inc. (US) | 2000-04-26 | — | — | EP | disclosed |
| US-6040320-A | ANTIINFLAMMATORY AGENT FOR TREATING DISEASES ASSOCIATED WITH OVERPRODUCTION OF INFLAMMATORY CYTOKINES, SUCH AS RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISEASE, SEPTIC SHOCK, OSTEOPOROSIS, AND OSTEOARTHRITIS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2000-03-21 | — | — | US | disclosed |
| EP-0950727-A1 | Ferroelectric thin films and solutions for their production | RAMTRON INTERNATIONAL CORPORATION (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5892129-A | Process for the preparation of 1,1,3-trialkoxypropane | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | disclosed |
| WO-1999003837-A1 | 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 1999-01-28 | — | — | WO | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| EP-0770425-A1 | Activation and regeneration of hydrogenation catalysts | BP Chemicals Limited (GB) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996030325-A1 | PROCESS FOR THE PURIFICATION OF 1,3-DIETHOXYPROPANE BY MEANS OF SUBATMOSPHERIC PRESSURE DISTILLATION | BP CHEMICALS LIMITED (GB) | 1996-10-03 | — | — | WO | disclosed |
| EP-0658155-A4 | PROCESS FOR CONVERTING ACETALS TO ETHERS. | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | disclosed |
| EP-0420806-B1 | Phosphonic acids, process for preparation and use as an active pharmaceutical composition | CIBA GEIGY AG (CH) | 1995-07-05 | — | — | EP | disclosed |
| EP-0658155-A1 | PROCESS FOR CONVERTING ACETALS TO ETHERS | BP Chemicals Limited (GB) | 1995-06-21 | — | — | EP | disclosed |
| WO-1995001949-A1 | PROCESS FOR CONVERTING ACETALS TO ETHERS | BP CHEMICALS LIMITED (GB) | 1995-01-19 | — | — | WO | disclosed |
| US-5079023-A | During consumption; beverages | HERCULES INCORPORATED (US) | 1992-01-07 | — | — | US | disclosed |
| EP-0420806-A1 | Phosphonic acids, process for preparation and use as an active pharmaceutical composition | CIBA-GEIGY AG (CH) | 1991-04-03 | — | — | EP | disclosed |
| US-4964895-A | Substituted 4-(4-nitrophenoxy) pyrazoles and their use as herbicides | MONSANTO COMPANY (US) | 1990-10-23 | — | — | US | disclosed |
| EP-0207097-B1 | NEW CARBONIC ACID ESTERS | CIBA-GEIGY AG (CH) | 1990-08-08 | — | — | EP | disclosed |
| EP-0158159-B1 | PROCESS FOR THE SYNTHESIS OF O-SUBSTITUTED OXIME COMPOUNDS AND THE CONVERSION THEREOF INTO THE CORRESPONDING HYDROXYLAMINE O-SUBSTITUTED | AlliedSignal Inc. (US) | 1988-10-05 | — | — | EP | disclosed |
| US-4764523-A | Novel carbonic acid esters | CIBA-GEIGY CORPORATION (US) | 1988-08-16 | — | — | US | disclosed |
| US-4639436-A | Antidiabetic 3,4,5-trihydroxypiperidines | BAYER AKTIENGESELLSCHAFT (DE) | 1987-01-27 | — | — | US | disclosed |
| EP-0207097-A1 | NEW CARBONIC ACID ESTERS. | CIBA GEIGY AG (CH) | 1987-01-07 | — | — | EP | disclosed |
| EP-0205481-A1 | NEW O-ACYLHYDROXAMIC ACID DERIVATIVES | CIBA-GEIGY AG (CH) | 1986-12-30 | — | — | EP | disclosed |
| WO-1986003747-A1 | NEW CARBONIC ACID ESTERS | CIBA-GEIGY AG (CH) | 1986-07-03 | — | — | WO | disclosed |
| WO-1986003745-A1 | NEW O-ACYLHYDROXAMIC ACID DERIVATIVES | CIBA-GEIGY AG (CH) | 1986-07-03 | — | — | WO | disclosed |
| EP-0028892-B1 | A HETERONUCLEAR-BRIDGED RHODIUM CLUSTER AND ITS APPLICATION AS CATALYST FOR HYDROFORMYLATION OF OLEFINS | UNION CARBIDE CORPORATION (US) | 1986-03-19 | — | — | EP | disclosed |
| US-4551477-A | ANTILIPEMIC AGENTS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1985-11-05 | — | — | US | disclosed |
| EP-0158159-A1 | Process for the synthesis of o-substituted oxime compounds and the conversion thereof into the corresponding hydroxylamine o-substituted | AlliedSignal Inc. (US) | 1985-10-16 | — | — | EP | disclosed |
| US-4533756-A | 2 OR 3-ETHOXY PROPIONALDEHYDE INTERMEDIATES | TEXACO INC. (US) | 1985-08-06 | — | — | US | disclosed |
| US-4348539-A | Heteronuclear-bridged rhodium clusters | UNION CARBIDE CORPORATION (US) | 1982-09-07 | — | — | US | disclosed |
| EP-0008058-B1 | N-AMINO-3,4,5-TRIHYDROXYPIPERIDINES, METHODS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM, METHOD FOR THE PRODUCTION OF THE MEDICAMENTS AND ANIMAL FEEDSTUFF CONTAINING SAID COMPOUNDS | BAYER AG (DE) | 1982-08-18 | — | — | EP | disclosed |
| US-4293551-A | N-Amino-3,4,5-trihydroxypiperidines, their production and their medicinal use | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
| US-4288380-A | Heteronuclear-bridged rhodium clusters | UNION CARBIDE CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| US-4280011-A | FLAVORINGS | HERCULES INCORPORATED (US) | 1981-07-21 | — | — | US | disclosed |
| EP-0028892-A1 | A heteronuclear-bridged rhodium cluster and its application as catalyst for hydroformylation of olefins | UNION CARBIDE CORPORATION (US) | 1981-05-20 | — | — | EP | disclosed |
| US-4260622-A | Animal feedstuffs employing 3,4,5-trihydroxypiperidines | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | disclosed |
| US-4230893-A | 1,1-Di(4-hydroxy-3-methoxyphenyl)-2-alkoxypropane | MERCK & CO., INC. (US) | 1980-10-28 | — | — | US | disclosed |
| US-4199572-A | DERIVATIVES OF SISOMICINS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-04-22 | — | — | US | disclosed |
| US-4199572-A | DERIVATIVES OF SISOMICINS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-04-22 | — | — | US | disclosed |